// App-Quantinova.ai

P1-01-03 : Dynamics of circulating tumor cells during the course of chemotherapy and prognostic relevance across molecular subtypes in high-risk early breast cancer patients Results from the adjuvant SUCCESS A trial

Researchers

Presenter

  • MLJ Tzschaschel

Principal Investigators

  • U Andergassen

  • TWP Friedl

  • A Schneeweiss

  • V Mueller

  • F Tanja

  • K Pantel

  • J Gade

  • R Lorenz

  • M Rezai

  • H Tesch

  • U Soeling

  • A Polasik

  • M Alunni-Fabbroni

  • EK Trapp

  • S Mahner

  • C Schindlbeck

  • W Lichtenegger

  • MW Beckmann

  • PA Fasching

  • W Janni

Medical Centers

  • Charite University Hospital Campus Virchow, Berlin, Germany

  • Gemeinschaftspraxis Siehl und Soeling, Cassel, Germany

  • Onkologische Gemeinschaftspraxis am Bethanien-Krankenhaus, Frankfurt/Main, Germany

  • National Center for Tumor Diseases, University of Heidelberg, Heidelberg, Germany

  • Clinics Traunstein, Traunstein, Germany

  • Ludwig Maximilians Universitaet Muenchen Klinik und Poliklinik fuer Frauenheilkunde und Gerburtshilfe, Munich, Germany

  • Diakoniekrankenhaus Friederikenstift, Hannover, Germany

  • Gemeinschaftspraxis Lorenz-Hecker-Wesche, Braunschweig, Germany

  • University of Ulm, Ulm, Germany

  • Heinrich Heine University Duesseldorf, Duesseldorf, Germany

  • University Medical Center Hamburg Eppendorf, Hamburg, Germany

  • Luisenkrankenhaus Dusseldorf, Senologie, Dusseldorf, Germany

  • Universitatsklinikum Hamburg-Eppendorf, Hamburg, Germany

  • University Hospital Erlangen, Friedrich-Alexander, Erlangen, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • Circulating tumor cells

  • Human epidermal growth factor receptor 2

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Fluorouracil

  • Adrucil injection

  • Gemcitabine

  • Epirubicin

  • Docetaxel

Outcome

  • N/A

Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved